Giorgia Chiodin

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and Survival.

DC-SIGN Binding to the Surface Ig Oligomannose-type Glycans Promotes Follicular Lymphoma Cell Adhesion and Survival.

Journal: Blood
Published: May 21, 2025

DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival.

DC-SIGN binding to the surface immunoglobulin oligomannose-type glycans promotes follicular lymphoma cell adhesion and survival.

Journal: Blood
Published: May 21, 2025

The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma.

The origin, diagnosis, and prognosis of oligomannose-type diffuse large B-cell lymphoma.

Journal: Blood
Published: March 14, 2025

Identification, assembly and characterization of tumor immunoglobulin transcripts from RNA sequencing data using IgSeqR.

Identification, assembly and characterization of tumor immunoglobulin transcripts from RNA sequencing data using IgSeqR.

Journal: Nature protocols
Published: February 23, 2024

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

FoxO1/Rictor axis induces a nongenetic adaptation to ibrutinib via Akt activation in chronic lymphocytic leukemia.

Journal: The Journal of clinical investigation
Published: July 11, 2023

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia.

Biological and Clinical Insight from Analysis of the Tumor B-Cell Receptor Structure and Function in Chronic Lymphocytic Leukemia.

Journal: Cancers
Published: December 01, 2021

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.

High surface IgM levels associate with shorter response to ibrutinib and BTK bypass in patients with CLL.

Journal: Blood advances
Published: November 23, 2021

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.

Insertion of atypical glycans into the tumor antigen-binding site identifies DLBCLs with distinct origin and behavior.

Journal: Blood
Published: April 09, 2021

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.

DC-SIGN binding to mannosylated B-cell receptors in follicular lymphoma down-modulates receptor signaling capacity.

Journal: Scientific reports
Published: November 09, 2020

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.

Changes in Bcl-2 members after ibrutinib or venetoclax uncover functional hierarchy in determining resistance to venetoclax in CLL.

Journal: Blood
Published: December 04, 2019

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.

Journal: Blood
Published: September 23, 2019

Hedgehog activation in CLL.

Hedgehog activation in CLL.

Journal: Blood
Published: June 22, 2019
Showing 1-12 of 17

Last Updated: 09/26/2026